RNA Pol II inhibitors (Hamlet BioPharma)

N/A

Report date: 2025/06/11 11:06:51
NME

Base Information

Drug NameRNA Pol II inhibitors (Hamlet BioPharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionRNA polymerase II inhibitors
TargetsRNA polymerase II
Therapy Area/IndicationsInflammationCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelectImmune Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesSelectImmune Pharma AB
Inactive CompaniesN/A
Active IndicationsInflammationCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A